Colgate-Palmolive (NYSE:CL) Price Target Raised to $107.00 at Deutsche Bank Aktiengesellschaft

Colgate-Palmolive (NYSE:CL) had its price objective increased by stock analysts at Deutsche Bank Aktiengesellschaft from $104.00 to $107.00 in a research report issued to clients and investors on Monday, Benzinga reports. The brokerage currently has a “buy” rating on the stock. Deutsche Bank Aktiengesellschaft’s price objective would suggest a potential upside of 6.61% from the company’s current price.

CL has been the topic of a number of other reports. Bank of America upped their price objective on Colgate-Palmolive from $100.00 to $110.00 and gave the company a “buy” rating in a research report on Wednesday, July 10th. Argus raised their price target on Colgate-Palmolive from $97.00 to $107.00 and gave the stock a “buy” rating in a research report on Wednesday, May 15th. TD Cowen started coverage on shares of Colgate-Palmolive in a research report on Tuesday, July 23rd. They set a “buy” rating and a $110.00 price objective on the stock. Citigroup raised their target price on shares of Colgate-Palmolive from $103.00 to $112.00 and gave the stock a “buy” rating in a report on Wednesday, July 10th. Finally, Barclays lifted their price target on shares of Colgate-Palmolive from $91.00 to $96.00 and gave the stock an “equal weight” rating in a research note on Monday. Five investment analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $99.42.

Colgate-Palmolive Price Performance

Shares of NYSE CL traded up $0.98 during midday trading on Monday, reaching $100.37. 2,103,687 shares of the stock traded hands, compared to its average volume of 4,383,921. The company’s 50 day moving average is $95.83 and its 200 day moving average is $90.20. Colgate-Palmolive has a one year low of $67.62 and a one year high of $100.90. The stock has a market capitalization of $82.35 billion, a PE ratio of 31.80, a P/E/G ratio of 3.57 and a beta of 0.39. The company has a debt-to-equity ratio of 13.21, a current ratio of 0.42 and a quick ratio of 0.28.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings data on Friday, July 26th. The company reported $0.91 EPS for the quarter, topping analysts’ consensus estimates of $0.87 by $0.04. The business had revenue of $5.06 billion during the quarter, compared to analysts’ expectations of $5 billion. Colgate-Palmolive had a net margin of 14.21% and a return on equity of 470.19%. The business’s revenue was up 4.9% on a year-over-year basis. During the same period last year, the company posted $0.77 EPS. On average, equities research analysts anticipate that Colgate-Palmolive will post 3.55 earnings per share for the current year.

Insider Activity

In other news, insider John W. Kooyman sold 3,497 shares of the company’s stock in a transaction on Tuesday, May 7th. The stock was sold at an average price of $93.47, for a total transaction of $326,864.59. Following the transaction, the insider now directly owns 3,181 shares of the company’s stock, valued at $297,328.07. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. In other news, insider John W. Kooyman sold 3,497 shares of the business’s stock in a transaction dated Tuesday, May 7th. The stock was sold at an average price of $93.47, for a total transaction of $326,864.59. Following the sale, the insider now owns 3,181 shares in the company, valued at $297,328.07. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Sally Massey sold 12,226 shares of the company’s stock in a transaction dated Thursday, May 9th. The shares were sold at an average price of $94.06, for a total transaction of $1,149,977.56. Following the transaction, the insider now owns 13,924 shares in the company, valued at approximately $1,309,691.44. The disclosure for this sale can be found here. Company insiders own 0.34% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of the company. Union Savings Bank lifted its position in Colgate-Palmolive by 76.6% during the fourth quarter. Union Savings Bank now owns 309 shares of the company’s stock valued at $25,000 after purchasing an additional 134 shares during the period. E Fund Management Hong Kong Co. Ltd. acquired a new position in shares of Colgate-Palmolive in the 2nd quarter valued at about $25,000. Avion Wealth boosted its stake in shares of Colgate-Palmolive by 78.1% in the fourth quarter. Avion Wealth now owns 399 shares of the company’s stock worth $32,000 after buying an additional 175 shares during the last quarter. Atlantic Edge Private Wealth Management LLC acquired a new stake in Colgate-Palmolive during the fourth quarter valued at $32,000. Finally, PSI Advisors LLC increased its holdings in Colgate-Palmolive by 4,971.4% in the first quarter. PSI Advisors LLC now owns 355 shares of the company’s stock valued at $32,000 after buying an additional 348 shares in the last quarter. 80.41% of the stock is currently owned by hedge funds and other institutional investors.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.